Billions in Uncovered Care: Orthopedics Tops List of Unreimbursed Treatments in Medical Institutions
Non-Covered Medical Expenses in South Korea Reach 422.1 Billion Won
The Ministry of Health and Welfare and the National Health Insurance Service released the results of the ‘2023 Second Half Non-covered Reporting System’ on their website, revealing that non-covered medical expenses at medical institutions in the second half of last year were close to 422.1 billion won.
By department, orthopedics had the largest amount at 117 billion won, followed by neurosurgery, internal medicine, general surgery, obstetrics and gynecology, pediatrics and adolescent medicine, rehabilitation medicine, and urology.
The non-covered treatment reporting system is a system in which medical institutions report non-covered treatment history to understand the status of non-covered treatment and guarantee the public’s right to know about non-covered treatment information and right to choose medical care.
Key Findings
- Total medical expenses for 594 items at hospital-level medical institutions in September 2023 amounted to KRW 422.1 billion.
- Hospitals accounted for the largest proportion at KRW 193.8 billion (45.9%).
- Orthopedic treatment costs accounted for the largest proportion at KRW 117 billion (27.7%).
- The top 10 items accounted for 45.3% of the total non-covered medical expenses.
Measures to Manage Non-Covered Treatment
The government plans to strengthen non-covered treatment management by establishing measures to manage non-serious excessive non-covered treatment that burdens the people’s medical expenses and health insurance finances.
In accordance with the first implementation plan for medical reform, the government will support rational medical choices for consumers by strengthening non-covered monitoring and expanding information provision.
The government will also promote overall non-covered standardization by collecting opinions from the medical field and developing non-covered standard treatment guidelines, standard names, codes, etc.
Restricting Concurrent Treatment Benefits
For non-serious non-covered treatments with a clear tendency for abuse, such as manual therapy, the government will consider restricting concurrent treatment benefits if medical necessity is low.
The government will also discuss ways to exclude from non-covered items technologies that are ineffective or have safety issues through periodic re-evaluation of medical technology and verification of effectiveness.
Conclusion
The government will analyze the data collected through the reporting system to provide information that is helpful for the people’s actual use of medical services, and continue to strengthen non-covered monitoring, such as by expanding the non-covered reporting system.
Kwon Byeong-gi, the director of the Essential Medical Support Division at the Ministry of Health and Welfare, emphasized the importance of strengthening non-covered monitoring and promoting overall non-covered standardization.
